| Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology’s Headache Study Group N Morollón, R Belvís, A De Dios, N Pagès, C González-Oria, G Latorre, ... Neurología (English Edition) 35 (9), 628-632, 2020 | 16 | 2020 |
| Feasibility of a new model of care for allogeneic stem cell transplantation recipients facilitated by eHealth: the MY-medula pilot study S Redondo, A De Dios, M Gomis-Pastor, A Esquirol, O Aso, M Triquell, ... Transplantation and Cellular Therapy 29 (6), 385. e1-385. e8, 2023 | 2 | 2023 |
| Developing a mHealth intervention to redesign the current journey for people living with HIV: A qualitative study. A De Dios, M Masip, P Riera, MDM Gutiérrez, MA Mangues, ... Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad …, 2022 | 2 | 2022 |
| Tratamientos habituales utilizados en cefaleas, neuralgias y SARS-CoV-2. Posicionamiento del grupo de estudio de cefaleas de la Sociedad Española de Neurología N Morollón, R Belvís, A De Dios, N Pagès, C González-Oria, G Latorre, ... Neurología 35 (9), 628-632, 2020 | 2 | 2020 |
| Does an eHealth Intervention Reduce Complications and Healthcare Resources? A mHeart Single-Center Randomized-Controlled Trial M Gomis-Pastor, S Mirabet Perez, A De Dios Lopez, V Brossa Loidi, ... Journal of Cardiovascular Development and Disease 10 (2), 77, 2023 | 1 | 2023 |
| What if a monoclonal antibody doesn't work as a migraine preventive treatment? Description of the experience in switching between monoclonals antibodies in a Headache Unit N Morollon, R Belvis, A De Dios, N Pages, M Massip JOURNAL OF HEADACHE AND PAIN 22 (SUPPL 1), 106-106, 2021 | 1 | 2021 |
| CP-204 Observational study on the use of different therapeutic alternatives for multiple sclerosis treatment A de Dios López, SJ Montaña, LS Parada, PAL Broseta, MM Marqués, ... European Journal of Hospital Pharmacy 24 (Suppl 1), A91-A91, 2017 | 1 | 2017 |
| Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement ME Moreno-Martinez, M Riba, I García-Cadenas, A Esquirol, M Yusta, ... Frontiers in Immunology 15, 1397115, 2024 | | 2024 |
| Clinical Validation of Digital Healthcare Solutions: State of the Art, Challenges and Opportunities M Gomis-Pastor, J Berdún, A Borrás-Santos, A De Dios López, ... Healthcare 12 (11), 1057, 2024 | | 2024 |
| 4CPS-091 Real-life persistence, effectiveness and safety of fremanezumab in patients with chronic migraine S Ojeda, P Riera, N Pagès, M Masip, R Pelegrin, A De Dios European Journal of Hospital Pharmacy 31 (Suppl 1), A95-A96, 2024 | | 2024 |
| MOBILE HEALTH IN THE MANAGEMENT OF ALLOGENIC STEM CELL TRANSPLANT RECIPIENTS (MY-MEDULA STUDY): IMPLEMENTATION PHASES AND PILOT STUDY RESULTS S Redondo, A De-Dios, A Esquirol, OA Merce Triquell, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 350-350, 2023 | | 2023 |
| Desarrollo de una intervención mHealth para rediseñar la ruta asistencial de las personas que viven con VIH: Estudio cualitativo A De Dios, M Masip, N Pagès-Puigdemont, P Riera, MG Mateo, ... FARMACIA HOSPITALARIA 46 (07), 47-58, 2022 | | 2022 |
| 70 or 140 mg to start? Predictive factors of response after 6 months to 70 mg of erenumab as a starting dose in patients with chronic migraine N Morollon, R Belvis, A De Dios, N Pages, M Massip JOURNAL OF HEADACHE AND PAIN 22 (SUPPL 1), 106-106, 2021 | | 2021 |
| Improving Patients’ Experience and Medication Adherence after Heart Transplant Using a Multilevel eHealth Intervention: The Mheart Clinical Trial M Gomis-Pastor, A de Dios López, SM Pérez, ER Minguell, VB Loidi, ... The Journal of Heart and Lung Transplantation 40 (4), S282, 2021 | | 2021 |
| ENFERMEDAD DE CROHN REFRACTARIA EN EL PACIENTE JOVEN A de Dios López, J del Estal Jiménez EN FARMACIA HOSPITALARIA, 51, 2021 | | 2021 |
| HIPERTENSIÓN Y EMBARAZO EN EL SÍNDROME URÉMICO-HEMOLÍTICO ATÍPICO A de Dios López, PAL Broseta EN FARMACIA HOSPITALARIA, 83, 2019 | | 2019 |
| 4CPS-044 Growth hormone therapy follow-up programme in paediatric patients J del Estal Jiménez, MM Marqués, SJ Montaña, PAL Broseta, ... European Journal of Hospital Pharmacy 25 (Suppl 1), A61-A61, 2018 | | 2018 |
| Omalizumab in chronic spontaneous urticaria M Martin Marques, A De Dios Lopez, S Jornet Montana, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 40 (1), 223-223, 2018 | | 2018 |
| The impact of a multidisciplinary team in antibiotic treatments in clinical practice A De Dios Lopez, G Garcia Pardo, M Olona Cabases, PA Lopez Broseta, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 40 (1), 305-305, 2018 | | 2018 |
| Evaluation of the hospital transition in intensive care unit patients after the implementation of a pharmacist L Canadell Vilarrasa, M Martin Marques, A De Dios Lopez, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 40 (1), 305-305, 2018 | | 2018 |
Neus Pagès-PuigdemontPharmD, PhD. Clinical Pharmacist. Hospital de la Santa Creu i Sant Pau (Barcelona)Verified email at santpau.cat
